癌症中的心房动,抗癌疗法,以及潜在的机制
Adnan Shaaban1, Shane S Scott2, Ashley N Greenlee3
1The Ohio State University College of Medicine, Department of Internal Medicine, Columbus, OH 43210, USA.
Journal of molecular and cellular cardiology
|June 19, 2024
概括
心房动 (AF) 在癌症患者中很常见,因癌症治疗而恶化. 本综述探讨了SGLT2抑制剂对于癌症患者的AF管理的共享机制和潜在益处.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心房动 (AF) 是癌症患者常见的并发症,常常被化疗和向癌症治疗加剧.
- 癌症患者中AF的发病率较高,独立于其他风险因素,如先前存在的心脏病,癌症类型或癌症阶段.
- AF导致心脏功能低效,导致疲劳和呼吸短促等症状,并增加由于血液静止而导致中风的风险,这在癌症中也很常见.
研究的目的:
- 审查心房动,癌症和心脏毒性抗癌疗法之间的复杂关系.
- 在癌症及其治疗的背景下阐明AF的共同分子和电生理机制.
- 调查-葡萄糖共运输体2抑制剂 (SGLT2i) 在治疗抗癌疗法诱导的AF中的潜在治疗作用.
主要方法:
- 这是一篇综述性文章,综合了现有研究.
- 专注于分析癌症,AF和心脏毒性之间的分子通路和电生理学特性.
- 审查了AF和癌症治疗的背景下SGLT2抑制剂的文献.
主要成果:
- 传统和向的抗癌疗法可以直接促进AF的发展和进展.
- 在接受治疗的癌症患者中,共享的分子和电生理路径有助于AF.
- SGLT2 抑制剂显示出作为治疗策略的潜力,用于管理抗癌疗法诱导的AF.
结论:
- 肌痛动脉是癌症患者的一个显著而复杂的并发症,通常与心脏毒性治疗有关.
- 了解共享机制对于开发有针对性的干预措施至关重要.
- SGLT2 抑制剂代表了缓解该脆弱人群中AF的有希望的途径.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:28Disturbances in Heart Rhythm
933
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
933
01:28Mechanism of Cardiac Arrhythmias
910
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
910
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:17Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K